Kyocera Sets World Record in Polycrystalline Solar Cell Conversion Efficiency

The Japanese technology corporation Kyocera (NYSE:KYO) (TOKYO:6971), one of the leading manufacturers in the solar sector, has achieved an efficiency of 16.6 per cent with polycrystalline solar modules. This success is the result of Kyocera’s proprietary back-contact technology.

The efficiency of 16.6 per cent (aperture area: 17.3 per cent efficiency) has been achieved in polycrystalline modules with 54 solar cells. In order to achieve this result, both the module design and the output of each individual cell were optimized. Back-contact technology involves transferring the current-carrying electrodes from the front to the rear side. This leads to an increase in the aperture area on the front of the module and hence to an improvement in efficiency.

Kyocera’s own energy conversion results already report efficiency levels of 18.5 per cent for polycrystalline solar cells still in the development stage.

The Kyocera Corporation is a front runner in the solar energy market and began to develop solar cells in 1975. Company founder Dr. Kazuo Inamori thus made a fundamental contribution to the solar industry. His achievements included stepping up the pace of series production for polycrystalline silicon. Since then, the company has gathered many years of experience and has established a close link to the solar industry. In its production, Kyocera attaches particular importance to covering the entire value-added chain itself and thus guaranteeing quality and performance of the modules.

Facts and Figures


Module efficiency                  16.6% (total area: 13,379 cm2)


Efficiency (absorption area)   17.3% (aperture area: 12,753 cm2)


Number of cells                     54 (dimensions: 150mm x 155mm)


Cell technology                      polycrystalline


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.